Literature DB >> 2070830

In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells.

H Nakahara1, J E Dennis, S P Bruder, S E Haynesworth, D P Lennon, A I Caplan.   

Abstract

Periosteal cells were enzymatically liberated from the tibiae of young chicks, introduced into cell culture, and allowed to reach confluence. The morphology of the cells gave the impression of a relatively homogeneous population of fibroblast-like cells. These cultured cells did not overtly express osteogenic or chondrogenic properties as judged by their morphology and the lack of reactivity with probes to phenotype-specific antigens of osteoblasts or chondrocytes. The cells were then replated at relatively high density and chronologically evaluated for the differentiation of bone and cartilage. These replated cells formed a multi-layer of fibroblast-like cells, the top portion of which eventually differentiated into bone tissue as evidenced by the presence of mineralization and immunocytochemical reactivity to bone Gla protein- and osteocyte-specific probes. Cells below this distinctive top layer differentiated into chondrocytes, which eventually further developed into hypertrophic chondrocytes as evidenced by their morphology and the presence of immunoreactive type X collagen in the matrix. Mineralization was also observed in the territorial matrix of these hypertrophic chondrocytes, when the culture was augmented with beta-glycerophosphate. Periosteal-derived cells replated at a lower density as controls did not show signs of osteochondrogenic differentiation. These observation suggest that periosteal-derived cells of young chicks contain mesenchymal cells which possess the potential to undergo terminal differentiation into osteogenic or chondrogenic phenotypes depending on local environmental or positional cues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2070830     DOI: 10.1016/0014-4827(91)90401-f

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  40 in total

Review 1.  Mesenchymal stem cells. A potential source for skeletal repair.

Authors:  W E Fibbe
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

2.  Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases.

Authors:  Alan Tyndall
Journal:  Transfus Med Hemother       Date:  2008-07-17       Impact factor: 3.747

3.  A novel method to examine the phenotype of chondrocytes.

Authors:  R Kuijer; D A Surtel; A J Van Der Linden; S K Bulstra; R C Passier
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

Review 4.  The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis.

Authors:  B K Hall; T Miyake
Journal:  Anat Embryol (Berl)       Date:  1992-07

5.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

Review 6.  Cellular therapy of systemic sclerosis.

Authors:  Jacob M van Laar; Alan Tyndall
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

Review 7.  An update on bone substitutes for spinal fusion.

Authors:  Masashi Miyazaki; Hiroshi Tsumura; Jeffrey C Wang; Ahmet Alanay
Journal:  Eur Spine J       Date:  2009-03-12       Impact factor: 3.134

8.  Mesenchymal progenitor cells derived from traumatized human muscle.

Authors:  W M Jackson; A B Aragon; F Djouad; Y Song; S M Koehler; L J Nesti; R S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2009-02       Impact factor: 3.963

9.  Practical Modeling Concepts for Connective Tissue Stem Cell and Progenitor Compartment Kinetics.

Authors:  George F. Muschler; Ronald J. Midura; Chizu Nakamoto
Journal:  J Biomed Biotechnol       Date:  2003

10.  Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues.

Authors:  Jiabo Hu; Zhongwei Zhou; Shunbin Shi; Xiaozhong Zhu; Xiaohui Wang; Wei Zhang; Sanqiang Hu; Hui Qian; Wenrong Xu
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.